[1]
C. Palmieri, E. Bird, and R. Simcock, Eds., ABC of cancer care. Chichester: Wiley-Blackwell, 2013.
[2]
P. Carlo, ABC of Cancer Care, 1st ed. John Wiley & Sons, Incorporated, 2013 [Online]. Available: https://ebookcentral.proquest.com/lib/suss/detail.action?docID=1207852
[3]
Cabot, Richard CHarris, Nancy Lee, MDRosenberg, Eric S, MDShepard, Jo-Anne O, MDCort, Alice M, MD, ‘Case 14-2013’, The New England Journal of Medicine, vol. 368, no. 19, pp. 1827–1835 [Online]. Available: http://search.proquest.com.ezproxy.brighton.ac.uk/docview/1349803228/99B6F5EFE846490BPQ/39?accountid=9727
[4]
P. Kaye, Breaking bad news: a 10 step approach. Northampton: EPL, 1996.
[5]
Jonathan Silverman, Suzanne Kurtz, and Juliet Draper, Skills for Communicating with Patients, 3rd Edition, 3rd ed. Chapman and Hall/CRC, 2016 [Online]. Available: https://ebookcentral.proquest.com/lib/ubrighton/detail.action?docID=4742673
[6]
J. Silverman, S. M. Kurtz, and J. Draper, Skills for communicating with patients, Third edition. London: Radcliffe Publishing, 2013.
[7]
S. M. Kurtz, J. Silverman, and J. Draper, Teaching and learning communication skills in medicine, 2nd ed. Abingdon: Radcliffe, 2005 [Online]. Available: https://sussex-primo.hosted.exlibrisgroup.com/primo-explore/fulldisplay?docid=44SUS_ALMA_DS2175116780002461&context=L&vid=44SUS_VU1&search_scope=44SUS_LIBRARY&tab=default&lang=en_US
[8]
D. D. Adler, M. B. Riba, and S. Eggly, ‘Breaking Bad News in the Breast Imaging Setting’, Academic Radiology, vol. 16, no. 2, pp. 130–135, Feb. 2009, doi: 10.1016/j.acra.2008.08.006.
[9]
M. Fujimori and Y. Uchitomi, ‘Preferences of Cancer Patients Regarding Communication of Bad News: A Systematic Literature Review’, Japanese Journal of Clinical Oncology, vol. 39, no. 4, pp. 201–216, Feb. 2009, doi: 10.1093/jjco/hyn159. [Online]. Available: https://watermark-silverchair-com.ezproxy.brighton.ac.uk/hyn159.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAA18wggNbBgkqhkiG9w0BBwagggNMMIIDSAIBADCCA0EGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMSH2qfQZyzb_syarDAgEQgIIDEn-kc3MoUjWSqtdv5-dQByAloz61JZaPQv8juYDKCsKBuK9fnmHgiMcchnsgWwLgPTbQ0VG_aBToNCOkxalbADIoAdTzEDGhmSeZ5i1t-c58RGc9D307k2CewDkv0Y50uDNYDBX8-CT8gh9TcRws_JXrMcrlx692JOaSezeJ_nika2xqWTWWThIur3Z3zJ2WHihKtKQ8J3D95HQDEgYspcUpYuqSEmFyTO3LMyGqt6cbhbvTrCVopjuF3MYL1tAhwwtGjrQvk7dcczgng8ilhBi619ipY3ustPmD38vpOB2vdCcSQlrUE_1BIHRRQ82dB-4arBhcT63i4lppHgW5lJPPCSygxtwi393zq2bUz_9545rLoMd08vBfu2MvIPA48mvdmSVqmaQSVh1iNVEtRQ1EMXAxvlX2Qb-7mwcV-K1fvumcCO2aXK2WrkJrhMyAtQ0RqLHJm954KxlZN_oXjodHbQsZPr3bajJt4VPcen5Zka4_r4xiG1HRZmS-JUZT_0sxExo4lGotsmirNe-OTYDIiovCexCUpNdIZOBpp3HAjMBpLceBjaFwT13l5bmLORn6wJp9YH81_JNsgRiSNFQqPIgRnlfsBMZ8JCYrQKLrGv39hNMdd_aWihnX1FoUWvlrEOgnDRgeBEta1uOA79sEsxnnKq15FHXVwFxvxCCs-iQaA7KP2ejf0EVf7r5VHlpsTXywa8vUvvM-WvQFcaEt_qJslinbWRR57mEEDUgXMXagcxVHjT5AJXLKAUlAmZUSUChVc1Qi7tm1y1hgzr_wLOkGGKLsHTTX-bwFcXLEcDvtF5GCRN4tiN3O7frVQlTt7W9XWWXvO2VaBT3oyYPaxb98Dx4aDMtGsZNtpJsa14NtaZgRQv0inecLsJz_3hwGBpRUW-_FofxY8qnjzo9bU1-gc0JpUJzxocBhQItBzOP3qNv8Ff3vp9f44WPb3q2FKwvEnBwqB23c39FBO2DszMlY_f34Y6bKwhDM0vJyFy4cRbTgo5a1QBYDtPDsceXfpstI8uQazOvY3ckmKYXmjg
[10]
Hanratty, BarbaraLowson, ElizabethHolmes, LouiseGrande, GunnJacoby, Ann, ‘Breaking bad news sensitively: what is important to patients in their last year of life?’, BMJ Supportive & Palliative Care, vol. 2, pp. 53–59 [Online]. Available: https://search.proquest.com/docview/1783997881/fulltext/D9074EB1CBE345A7PQ/1?accountid=9727
[11]
Hamilton, W, ‘The CAPER studies: five case-control studies aimed at identifying and quantifying the risk of cancer in symptomatic primary care patients’, The British Journal of Cancer, vol. 101, no. 1 [Online]. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2790706/
[12]
Alfred G. Knudson, Jr., ‘Mutation and Cancer: Statistical Study of Retinoblastoma’, Proceedings of the National Academy of Sciences of the United States of America, vol. 68, no. 4, 1971 [Online]. Available: https://www-jstor-org.sussex.idm.oclc.org/stable/60687?sid=primo
[13]
A. Gawande and Wellcome Collection, Being mortal: illness, medicine and what matters in the end. London: Profile Books, 2015.
[14]
‘Being Mortal’, 2014. [Online]. Available: https://sussex-primo.hosted.exlibrisgroup.com/primo-explore/fulldisplay?docid=44SUS_ALMA_DS51112977480002461&context=L&vid=44SUS_VU1&search_scope=44SUS_LIBRARY&isFrbr=true&tab=default&lang=en_US
[15]
S. Mukherjee, The emperor of all maladies: a biography of cancer. London: Fourth Estate, 2011 [Online]. Available: https://sussex-primo.hosted.exlibrisgroup.com/primo-explore/fulldisplay?docid=44SUS_ALMA_DS2189620360002461&context=L&vid=44SUS_VU1&search_scope=44SUS_LIBRARY&tab=default&lang=en_US
[16]
S. Clark, A guide to cancer genetics in clinical practice. Harley: TFM, 2009.
[17]
H. V. Firth, J. A. Hurst, and J. G. Hall, Oxford desk reference: clinical genetics. Oxford: Oxford University Press, 2005.
[18]
‘Gene Reviews via the NCBI website : National Center for Biotechnology Information’. [Online]. Available: https://www.ncbi.nlm.nih.gov/
[19]
‘OMIM - Online Mendelian Inheritance in Man’. [Online]. Available: https://omim.org/
[20]
J. Sorace, D. R. Aberle, D. Elimam, S. Lawvere, O. Tawfik, and W. D. Wallace, ‘Integrating pathology and radiology disciplines: an emerging opportunity?’, BMC Medicine, vol. 10, no. 1, Dec. 2012, doi: 10.1186/1741-7015-10-100.
[21]
‘Royal College of Pathologists datasets for histopathology reporting on cancers’. [Online]. Available: https://www.rcpath.org/profession/guidelines/cancer-datasets-and-tissue-pathways.html
[22]
D. Hanahan and R. A. Weinberg, ‘The Hallmarks of Cancer’, Cell, vol. 100, no. 1, pp. 57–70, Jan. 2000, doi: 10.1016/S0092-8674(00)81683-9.
[23]
J. E. Husband and R. H. Reznek, Husband & Reznek’s imaging in oncology, 3rd ed. London: Informa Healthcare, 2010 [Online]. Available: http://www.vlebooks.com/vleweb/product/openreader?id=Brighton&isbn=9780415874984
[24]
American Joint Committee on Cancer, AJCC cancer staging handbook: from the AJCC Cancer staging manual, 7th ed. London: Springer, 2010 [Online]. Available: https://sussex-primo.hosted.exlibrisgroup.com/primo-explore/fulldisplay?docid=44SUS_ALMA_DS2188698760002461&context=L&vid=44SUS_VU1&search_scope=44SUS_LIBRARY&tab=default&lang=en_US
[25]
V. Grégoire et al., ‘Delineation of the neck node levels for head and neck tumors: A 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines’, Radiotherapy and Oncology, vol. 110, no. 1, pp. 172–181, Jan. 2014, doi: 10.1016/j.radonc.2013.10.010.
[26]
B. Li, Q. Li, W. Nie, and S. Liu, ‘Diagnostic value of whole-body diffusion-weighted magnetic resonance imaging for detection of primary and metastatic malignancies: A meta-analysis’, European Journal of Radiology, vol. 83, no. 2, pp. 338–344, Feb. 2014, doi: 10.1016/j.ejrad.2013.11.017.
[27]
‘Whole-Body Diffusion-Weighted MRI: Tips, Tricks, and Pitfalls: American Journal of Roentgenology’, American Journal of Roentgenology [Online]. Available: https://www.ajronline.org/doi/abs/10.2214/AJR.11.7866
[28]
Goh V, Ng QS, Miles K., ‘Computed tomography perfusion imaging for therapeutic assessment: has it come of age as a biomarker in oncology?’, vol. 47, no. 1, 2012 [Online]. Available: https://contentstore.cla.co.uk/secure/link?id=0968f686-0873-e911-80cd-005056af4099
[29]
‘Imaging for Staging and Response Assessment in Lymphoma : Radiology’ [Online]. Available: http://pubs.rsna.org.ezproxy.brighton.ac.uk/doi/full/10.1148/radiol.2015142088
[30]
B. D. Cheson et al., ‘Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification’, Journal of Clinical Oncology, vol. 32, no. 27, pp. 3059–3067, Sep. 2014, doi: 10.1200/JCO.2013.54.8800.
[31]
M. A. Dimopoulos et al., ‘Role of Magnetic Resonance Imaging in the Management of Patients With Multiple Myeloma: A Consensus Statement’, Journal of Clinical Oncology, vol. 33, no. 6, pp. 657–664, Feb. 2015, doi: 10.1200/JCO.2014.57.9961.
[32]
Dow-Mu Koh, Matthew Blackledge, and Anwar R. Padhani et al, ‘Whole-Body Diffusion-Weighted MRI: Tips, Tricks, and Pitfalls’ [Online]. Available: https://www.ajronline.org/doi/abs/10.2214/AJR.11.7866
[33]
L. L. Berland et al., ‘Managing Incidental Findings on Abdominal CT: White Paper of the ACR Incidental Findings Committee’, Journal of the American College of Radiology, vol. 7, no. 10, pp. 754–773, Oct. 2010, doi: 10.1016/j.jacr.2010.06.013.
[34]
R. M. Gore, D. R. Wenzke, K. H. Thakrar, G. M. Newmark, U. K. Mehta, and J. W. Berlin, ‘The incidental cystic pancreas mass: a practical approach’, Cancer Imaging, vol. 12, no. 2, pp. 414–421, 2012, doi: 10.1102/1470-7330.2012.9054.
[35]
‘Personalized Tumor Response Assessment in the Era of Molecular Medicine: Cancer-Specific and Therapy-Specific Response Criteria to Complement Pitfalls of RECIST : American Journal of Roentgenology’ [Online]. Available: http://www.ajronline.org.ezproxy.brighton.ac.uk/doi/abs/10.2214/AJR.11.7483
[36]
E. A. Eisenhauer et al., ‘New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)’, European Journal of Cancer, vol. 45, no. 2, pp. 228–247, Jan. 2009, doi: 10.1016/j.ejca.2008.10.026.
[37]
‘Response Criteria in Oncologic Imaging: Review of Traditional and New Criteria : RadioGraphics’ [Online]. Available: http://pubs.rsna.org/doi/full/10.1148/rg.335125214
[38]
‘A Radiologist’s Guide to Treatment Response Criteria in Oncologic Imaging: Anatomic Imaging Biomarkers : American Journal of Roentgenology’ [Online]. Available: http://www.ajronline.org.ezproxy.brighton.ac.uk/doi/abs/10.2214/AJR.12.9862
[39]
‘Neoplastic Invasion of Laryngeal Cartilage: Reassessment of Criteria for Diagnosis at MR Imaging’ [Online]. Available: https://pubs.rsna.org/doi/10.1148/radiol.2492072183
[40]
J. Vardy et al., ‘Long-term outcome of radiological-guided insertion of implanted central venous access port devices (CVAPD) for the delivery of chemotherapy in cancer patients: institutional experience and review of the literature’, British Journal of Cancer, vol. 91, no. 6, pp. 1045–1049, Sep. 2004, doi: 10.1038/sj.bjc.6602082.
[41]
Mehanna, HishamWong, Wai-LupMcConkey, Christopher CRahman, Joy KRobinson, Max, ‘PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer’, The New England Journal of Medicine, vol. 374, no. 15, pp. 1444–1454 [Online]. Available: http://search.proquest.com.ezproxy.brighton.ac.uk/docview/1781205526/AECA702A9F2C499DPQ/4?accountid=9727
[42]
Balaji Ganeshan, ‘Quantifying tumour heterogeneity with CT’, Cancer Imaging, vol. 13, no. 1, 2013, doi: doi: 10.1102/1470-7330.2013.0015. [Online]. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613789/
[43]
‘British Thyroid Association Guidelines’. [Online]. Available: https://www.british-thyroid-association.org/current-bta-guidelines-and-statements
[44]
‘British Thoracic Society Guidelines for the investigation and management of pulmonary nodules’. [Online]. Available: https://www.brit-thoracic.org.uk/document-library/clinical-information/pulmonary-nodules/bts-guidelines-for-pulmonary-nodules/
[45]
‘NICE Suspected cancer: recognition and referral | Guidance and guidelines’ [Online]. Available: https://www.nice.org.uk/guidance/ng12?unlid=9874814692015129115552,5161700902016923910
[46]
Fleissig, AnneJenkins, ValerieCatt, SusanFallowfield, Lesley, ‘Multidisciplinary teams in cancer care: are they effective in the UK?’, Lancet Oncology, vol. 7, no. 11, pp. 935–43 [Online]. Available: http://search.proquest.com.ezproxy.brighton.ac.uk/docview/200993543/B199001EC4DE4BBFPQ/31?accountid=9727
[47]
A. J. Munro, ‘Multidisciplinary Team Meetings in Cancer Care: An Idea Whose Time has Gone?’, Clinical Oncology, vol. 27, no. 12, pp. 728–731, Dec. 2015, doi: 10.1016/j.clon.2015.08.008.
[48]
R. Jalil, M. Ahmed, J. S. A. Green, and N. Sevdalis, ‘Factors that can make an impact on decision-making and decision implementation in cancer multidisciplinary teams: An interview study of the provider perspective’, International Journal of Surgery, vol. 11, no. 5, pp. 389–394, Jun. 2013, doi: 10.1016/j.ijsu.2013.02.026.
[49]
B. Lamb, H. Payne, C. Vincent, N. Sevdalis, and J. S. A. Green, ‘The role of oncologists in multidisciplinary cancer teams in the UK: an untapped resource for team leadership?’, Journal of Evaluation in Clinical Practice, vol. 17, no. 6, pp. 1200–1206, Dec. 2011, doi: 10.1111/j.1365-2753.2010.01507.x.
[50]
‘NHS Cancer Action Team: Quality in Nursing: Excellence in Cancer Care: The contribution of the Clinical Nurse Specialist’. [Online]. Available: https://www.macmillan.org.uk/documents/aboutus/commissioners/excellenceincancercarethecontributionoftheclinicalnursespecialist.pdf
[51]
D. Clark, M. Armstrong, A. Allan, F. Graham, A. Carnon, and C. Isles, ‘Imminence of death among hospital inpatients: Prevalent cohort study’, Palliative Medicine, vol. 28, no. 6, pp. 474–479, Jun. 2014, doi: 10.1177/0269216314526443.
[52]
M. Costantini et al., ‘Liverpool Care Pathway for patients with cancer in hospital: a cluster randomised trial’, The Lancet, vol. 383, no. 9913, pp. 226–237, Jan. 2014, doi: 10.1016/S0140-6736(13)61725-0.
[53]
Campion, Edward WKelley, Amy SMorrison, R Sean, ‘Palliative Care for the Seriously Ill’, The New England Journal of Medicine, vol. 373, no. 8, pp. 747–755 [Online]. Available: http://search.proquest.com.ezproxy.brighton.ac.uk/docview/1705787576/C2817B3DB58F4ADCPQ/8?accountid=9727
[54]
P. May et al., ‘Prospective Cohort Study of Hospital Palliative Care Teams for Inpatients With Advanced Cancer: Earlier Consultation Is Associated With Larger Cost-Saving Effect’, Journal of Clinical Oncology, vol. 33, no. 25, pp. 2745–2752, Sep. 2015, doi: 10.1200/JCO.2014.60.2334.
[55]
Temel, Jennifer S, MDGreer, Joseph A, PhDMuzikansky, Alona, MAGallagher, Emily R, RNAdmane, Sonal, MB, BS, MPH, ‘Early Palliative Care for Patients with Metastatic Non-Small-Cell Lung Cancer’, The New England Journal of Medicine, vol. 363, no. 8, pp. 733–42 [Online]. Available: http://search.proquest.com.ezproxy.brighton.ac.uk/docview/746045208/D2D08130C77249DFPQ/1?accountid=9727
[56]
‘National Confidential Enquiry into Patient Outcome and Death’. [Online]. Available: https://www.ncepod.org.uk/2008report3/Downloads/SACT_report.pdf
[57]
‘Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening’, The New England Journal of Medicine, vol. 365, no. 5, pp. 395–409 [Online]. Available: http://search.proquest.com.ezproxy.brighton.ac.uk/docview/881546508/4102C883EC5E4D19PQ/3?accountid=9727
[58]
Black, William CGareen, Ilana FSoneji, Samir SSicks, JoRean DKeeler, Emmett B, ‘Cost-Effectiveness of CT Screening in the National Lung Screening Trial’, The New England Journal of Medicine, vol. 371, no. 19, pp. 1793–802 [Online]. Available: http://search.proquest.com.ezproxy.brighton.ac.uk/docview/1621375459/F618EBF5604B46B2PQ/2?accountid=9727
[59]
M. Jefford, J. Rowland, E. Grunfeld, M. Richards, J. Maher, and A. Glaser, ‘Implementing improved post-treatment care for cancer survivors in England, with reflections from Australia, Canada and the USA’, British Journal of Cancer, vol. 108, no. 1, pp. 14–20, Jan. 2013, doi: 10.1038/bjc.2012.554.
[60]
‘Living with and Beyond Cancer. Taking Action to Improve Outcomes’. [Online]. Available: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/181054/9333-TSO-2900664-NCSI_Report_FINAL.pdf
[61]
V. T. DeVita, T. S. Lawrence, and S. A. Rosenberg, Eds., DeVita, Hellman, and Rosenberg’s cancer: principles & practice of oncology, Tenth edition. Philadelphia: Wolters Kluwer, 2015.
[62]
DeVita, Hellman, and Rosenberg’s Cancer : Principles & Practice of Oncology, 10th ed. Wolters Kluwer Health, 2014 [Online]. Available: https://ebookcentral.proquest.com/lib/suss/detail.action?docID=2035697
[63]
P. J. Hoskin, External beam therapy, 2nd ed., vol. Radiotherapy in practice. Oxford: Oxford University Press, 2012.
[64]
P. J. Hoskin and C. Coyle, Brachytherapy, 2nd ed., vol. Radiotherapy in practice. Oxford: Oxford University Press, 2011.
[65]
P. J. Hoskin and V. Goh, Imaging, vol. Radiotherapy in practice. Oxford: Oxford University Press, 2009.
[66]
P. J. Hoskin, Radioisotope therapy, vol. Radiotherapy in practice. Oxford: Oxford University Press, 2007.
[67]
‘Practical Radiotherapy Planning: Contouring Atlases’. [Online]. Available: https://www.rtog.org/CoreLab/ContouringAtlases.aspx
[68]
J. Arends et al., ‘ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology’, Clinical Nutrition, vol. 25, no. 2, pp. 245–259, Apr. 2006, doi: 10.1016/j.clnu.2006.01.020.
[69]
N. G. Burnet, ‘Defining the tumour and target volumes for radiotherapy’, Cancer Imaging, vol. 4, no. 2, pp. 153–161, 2004, doi: 10.1102/1470-7330.2004.0054.
[70]
Y. Tokuhashi, H. Matsuzaki, H. Oda, M. Oshima, and J. Ryu, ‘A Revised Scoring System for Preoperative Evaluation of Metastatic Spine Tumor Prognosis’, Spine, vol. 30, no. 19, pp. 2186–2191, Oct. 2005, doi: 10.1097/01.brs.0000180401.06919.a5.
[71]
‘Nutrition support for adults: oral nutrition support, enteral tube feeding and parenteral nutrition | Guidance and guidelines | NICE’ [Online]. Available: https://www.nice.org.uk/guidance/cg32
[72]
‘Metastatic spinal cord compression in adults | Guidance and guidelines | NICE’ [Online]. Available: https://www.nice.org.uk/guidance/qs56
[73]
‘Neutropenic sepsis: prevention and management in people with cancer | Guidance and guidelines | NICE’ [Online]. Available: https://www.nice.org.uk/guidance/cg151
[74]
‘NICE IPG79 (2004) Stent placement for vena caval obstruction’ [Online]. Available: https://www.nice.org.uk/guidance/ipg79
[75]
‘MDT Development’ [Online]. Available: http://www.ncin.org.uk/cancer_type_and_topic_specific_work/multidisciplinary_teams/mdt_development
